Halomonth

Halomonth Brand names, Halomonth Analogs

Halomonth Brand Names Mixture

No information avaliable

Halomonth Chemical_Formula

C₂₈H₂₉F₂N₃O

Halomonth RX_link

http://www.rxlist.com/cgi/generic3/orap.htm

Halomonth fda sheet

Halomonth msds (material safety sheet)

Halomonth MSDS

Halomonth Synthesis Reference

No information avaliable

Halomonth Molecular Weight

461.546 g/mol

Halomonth Melting Point

214-218 ^oC

Halomonth H₂O Solubility

10 mg/L

Halomonth State

Solid

Halomonth LogP

5.761

Halomonth Dosage Forms

Tablet

Halomonth Indication

Used for the suppression of motor and phonic tics in patients with Tourette's Disorder who have failed to respond satisfactorily to standard treatment.

Halomonth Pharmacology

Pimozide is an orally active antipsychotic drug product which shares with other antipsychotics the ability to blockade dopaminergic receptors on neurons in the central nervous system. However, receptor blockade is often accompanied by a series of secondary alterations in central dopamine metabolism and function which may contribute to both pimozide's therapeutic and untoward effects. In addition, pimozide, in common with other antipsychotic drugs, has various effects on other central nervous system receptor systems which are not fully characterized. Pimozide also has less potential for inducing sedation and hypotension as it has more specific dopamine receptor blocking activity than other neuroleptic agents (and is therefore a suitable alternative to haloperidol).

Halomonth Absorption

Greater than 50% absorption after oral administration. Serum peak appears 6-8 hours post ingestion.

Halomonth side effects and Toxicity

LD₅₀ = 1100 mg/kg (rat, oral), 228 mg/kg (mouse, oral)

Halomonth Patient Information